Europe • Euronext Milan • BIT:1TEM • US88023B1035
The current stock price of 1TEM.MI is 51.44 EUR.
ChartMill assigns a technical rating of 2 / 10 to 1TEM.MI.
ChartMill assigns a fundamental rating of 3 / 10 to 1TEM.MI. The financial health of 1TEM.MI is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months 1TEM.MI reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS increased by 85.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.94% | ||
| ROE | -40.15% | ||
| Debt/Equity | 2.45 |
For the next year, analysts expect an EPS growth of 75.39% and a revenue growth 81.58% for 1TEM.MI
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
TEMPUS AI INC
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 2400
Phone: 18335144187
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
The current stock price of 1TEM.MI is 51.44 EUR. The price decreased by -11.37% in the last trading session.
1TEM.MI does not pay a dividend.
1TEM.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
TEMPUS AI INC (1TEM.MI) operates in the Health Care sector and the Life Sciences Tools & Services industry.
TEMPUS AI INC (1TEM.MI) has a market capitalization of 9.15B EUR. This makes 1TEM.MI a Mid Cap stock.
You can find the ownership structure of TEMPUS AI INC (1TEM.MI) on the Ownership tab.